Category M reimbursement prices will be reduced from August by £15 million per month for a 12-month period. The reductions correct overpayments of retained margin for both 2015/16 and 2016/17.

The £15 million monthly reduction represents a drop of around 17-18p per item in average item value from current Drug Tariff prices, although the impact on any individual pharmacy may differ according to its dispensing mix.

Peter Cattee, chair of PSNC’s funding and contract sub-committee, said: “It is always difficult when the margins survey shows that contractors have received more than the allowed margin in any given year. This has particularly been the case in a year in which our businesses have come under a huge amount of pressure as funding has been squeezed.”

PSNC felt the priority was to spread the [overpayments] recovery over as long a period as possible, he said.

Sue Sharpe, PSNC chief executive, said the DH acknowledged that the impact of the Category M readjustments on community pharmacy would be “severe” in light of the recent funding cuts.

“Over many years we have seen that price volatility operates to preclude any real possibility of delivery of the exact agreed sum of margin in year,” she remarked. “We also remain concerned about fair access to margin and local manipulation of the market. The DH has recognised these issues and agreed to work with PSNC to try to resolve them.”

The impact on contractors will be severe

Originally Published by Pharmacy Magazine

Recommended

New education standards for pharmacy technicians

The GPhC has launched new standards for the initial education and training of pharmacy technicians

GPhC welcomes positive PSA review

The GPhC has met all of the Professional Standards Authority’s standards for good regulation in 2016/17

Popular

Making habits last a lifetime

Falling activity levels in young people are deeply concerning, say experts, so what can be done to encourage youngsters ...

Raising awareness of pancreatic cancer

Public awareness of pancreatic cancer has been slow to catch up with other forms of the disease. So what is this devasta...

Taking on pancreatic cancer

Pancreatic Cancer Action chief executive Ali Stunt speaks to TM about the work the charity does to raise awareness of t...